FP400 (n=22) | BDP800 (n=21) |
FP750 (n=13) | BDP1500 (n=13) | |
Men | 17 (77%) | 13 (62%) | 9 (69%) | 7 (54%) |
Women | 5 (23%) | 8 (38%) | 4 (31%) | 6 (46%) |
Age (years)1-150 | 39 (8) | 38 (8) | 38 (10) | 40 (10) |
Caucasian | 21 (95%) | 21 (100%) | 12 (92%) | 12 (92%) |
Height (cm)1-150 | 174 (6) | 171 (10) | 172 (8) | 170 (8) |
Weight (kg)1-150 | 75 (10) | 70 (14) | 74 (13) | 64 (12) |
Baseline | ||||
% Predicted FEV1 1-150 | 79.9 (18.9) | 90.2 (14.0) | 75.0 (20.7) | 78.2 (14.8) |
Baseline | ||||
% Predicted clinic PEF1-150 | 88.7 (15.1) | 97.8 (17.2) | 78.4 (30.2) | 89.6 (27.1) |
Duration of asthma (n) | ||||
<12 years | 2 | 0 | 0 | 0 |
⩾12 years | 20 | 21 | 13 | 13 |
History of smoking, n (%) | ||||
Never | 11 (50%) | 13 (62%) | 6 (46%) | 6 (46%) |
Ex-smoker | 8 (36%) | 7 (38%) | 4 (31%) | 4 (31%) |
Current | 3 (14%) | 1 (5%) | 3 (23%) | 3 (23%) |
FP400 = fluticasone propionate 400 μg/day (200 μg bd); FP750 = fluticasone propionate 750 μg/day (375 μg bd); BDP800 = beclomethasone dipropionate 800 μg/day (400 μg bd); BDP1500 = beclomethasone dipropionate 1500 μg/day (750 μg bd); FEV1 = forced expiratory volume in one second; PEF = peak expiratory flow.
↵1-150 Values are mean (SD).